Bioscience research firm Metabolix (MBLX +2.6%) trades higher this morning after Piper Jaffray...

|By:, SA News Editor

Bioscience research firm Metabolix (MBLX +2.6%) trades higher this morning after Piper Jaffray ups the shares to neutral on valuation.